Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Greenfield

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
Pageof 7